国药一致
(000028)
| 流通市值：117.31亿 | | | 总市值：136.58亿 |
| 流通股本：4.78亿 | | | 总股本：5.57亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 5,179,155,635.24 | 7,802,381,494.2 | 5,645,915,765.38 | 6,797,307,998.31 |
| 应收票据及应收账款 | 24,286,199,219.59 | 21,933,332,669.46 | 25,203,363,810.76 | 24,132,414,760.74 |
| 其中：应收票据 | 387,069,825.83 | 395,008,082.75 | 395,986,084.81 | 385,257,647.22 |
| 应收账款 | 23,899,129,393.76 | 21,538,324,586.71 | 24,807,377,725.95 | 23,747,157,113.52 |
| 应收款项融资 | 1,148,099,434.76 | 1,002,830,735.51 | 983,389,852.75 | 730,289,148.84 |
| 预付款项 | 283,901,550.57 | 408,218,855.84 | 282,107,003.04 | 344,838,163.22 |
| 其他应收款合计 | 611,954,880.05 | 591,737,333.31 | 557,913,663.23 | 611,100,198.19 |
| 应收股利 | - | - | - | 33,428,440.4 |
| 存货 | 8,473,670,184.13 | 8,121,516,928.61 | 8,341,948,399.43 | 8,064,362,078.21 |
| 合同资产 | 2,068,423.57 | 2,981,548.9 | 6,901,782.2 | 7,565,319.8 |
| 其他流动资产 | 323,298,873.37 | 332,752,975.88 | 146,088,469.82 | 174,868,328.5 |
| 流动资产合计 | 40,308,348,201.28 | 40,195,752,541.71 | 41,167,628,746.61 | 40,862,745,995.81 |
| 非流动资产: | | | | |
| 长期股权投资 | 3,236,445,561.16 | 3,166,315,160.28 | 3,078,795,255.32 | 3,050,067,793.84 |
| 其他权益工具投资 | 12,420,792.78 | 12,420,792.78 | 9,760,710.7 | 9,760,710.7 |
| 其他非流动金融资产 | 96,797,786.27 | 99,124,870.95 | 121,035,235.31 | 121,035,235.31 |
| 投资性房地产 | 81,474,305.35 | 82,343,037.96 | 83,277,482.58 | 84,169,306.26 |
| 固定资产 | 750,183,608.79 | 784,573,202.85 | 799,355,403.5 | 819,707,261.14 |
| 在建工程 | 17,933,315.17 | 21,662,133.24 | 20,588,421.7 | 14,840,783.8 |
| 使用权资产 | 1,789,656,568.91 | 1,886,036,888.19 | 2,094,833,512.66 | 2,248,125,323.89 |
| 无形资产 | 397,958,716.59 | 406,690,677.91 | 449,101,562.34 | 463,333,701.74 |
| 商誉 | 1,604,919,504.76 | 1,604,919,504.76 | 1,858,837,313.13 | 1,858,837,313.13 |
| 长期待摊费用 | 309,168,199.34 | 335,232,809.88 | 357,858,101.74 | 387,042,082.53 |
| 递延所得税资产 | 322,299,936.92 | 308,722,894.99 | 298,899,053.16 | 279,267,336.72 |
| 其他非流动资产 | 196,169,688.77 | 192,476,463.53 | 218,891,781.93 | 227,202,942.09 |
| 非流动资产合计 | 8,815,427,984.81 | 8,900,518,437.32 | 9,391,233,834.07 | 9,563,389,791.15 |
| 资产总计 | 49,123,776,186.09 | 49,096,270,979.03 | 50,558,862,580.68 | 50,426,135,786.96 |
| 流动负债: | | | | |
| 短期借款 | 2,522,437,530.56 | 2,602,187,146.51 | 3,538,138,064.18 | 4,338,721,950.75 |
| 应付票据及应付账款 | 20,518,159,013.61 | 20,515,902,140.83 | 21,350,575,362.14 | 19,830,794,511.86 |
| 其中：应付票据 | 9,003,920,128.64 | 10,156,529,347.13 | 8,500,204,277.68 | 8,021,130,202.43 |
| 应付账款 | 11,514,238,884.97 | 10,359,372,793.7 | 12,850,371,084.46 | 11,809,664,309.43 |
| 预收款项 | 17,943,391.52 | 19,970,057.08 | 20,321,693.44 | 19,549,786.69 |
| 合同负债 | 361,489,559.28 | 367,240,295.88 | 294,068,496.34 | 304,500,975.73 |
| 应付职工薪酬 | 202,911,032.54 | 271,257,980.87 | 254,603,142.6 | 207,688,826.49 |
| 应交税费 | 328,227,196.14 | 324,066,480.06 | 326,016,310.91 | 303,332,911.99 |
| 其他应付款合计 | 1,194,686,097.98 | 1,222,130,452.49 | 817,081,000.2 | 1,551,784,495.22 |
| 其中:应付利息 | 17,629,685.09 | 25,738,175.17 | 16,061,682.85 | 31,876,382.12 |
| 应付股利 | 10,538,824.46 | 10,538,824.46 | 10,538,824.46 | 10,538,824.46 |
| 一年内到期的非流动负债 | 710,902,999.87 | 740,454,403.44 | 827,828,090.49 | 872,864,566.63 |
| 其他流动负债 | 40,834,762.01 | 41,933,859.45 | 32,777,801.75 | 34,149,016.01 |
| 流动负债合计 | 25,897,591,583.51 | 26,105,142,816.61 | 27,461,409,962.05 | 27,463,387,041.37 |
| 非流动负债: | | | | |
| 租赁负债 | 862,199,035.28 | 912,182,012.68 | 1,022,413,794.11 | 1,112,668,732.78 |
| 长期应付款 | 6,938,189 | 6,938,189 | 6,938,189 | 6,938,189 |
| 长期应付职工薪酬 | 611,000 | 611,000 | 678,000 | 678,000 |
| 预计负债 | 122,839.55 | 311,617.52 | - | - |
| 递延收益 | 67,711,322.71 | 68,483,353.92 | 65,290,594.6 | 66,399,139.22 |
| 递延所得税负债 | 89,590,882.16 | 93,869,252.66 | 106,028,359.17 | 107,406,534.1 |
| 其他非流动负债 | 286,307,756.39 | 284,248,183.13 | 350,430,039.89 | 418,236,225.45 |
| 非流动负债合计 | 1,313,481,025.09 | 1,366,643,608.91 | 1,551,778,976.77 | 1,712,326,820.55 |
| 负债合计 | 27,211,072,608.6 | 27,471,786,425.52 | 29,013,188,938.82 | 29,175,713,861.92 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 556,565,077 | 556,565,077 | 556,565,077 | 556,565,077 |
| 资本公积 | 4,267,617,637.91 | 4,267,617,637.91 | 4,267,617,637.91 | 4,265,054,425.21 |
| 其他综合收益 | -276,281.1 | -276,281.1 | -1,485,019.87 | -1,485,019.87 |
| 盈余公积 | 278,282,538.5 | 278,282,538.5 | 278,282,538.5 | 278,282,538.5 |
| 未分配利润 | 13,795,236,803.58 | 13,507,774,303.26 | 13,328,965,937.95 | 13,037,754,780.86 |
| 归属于母公司股东权益合计 | 18,897,425,775.89 | 18,609,963,275.57 | 18,429,946,171.49 | 18,136,171,801.7 |
| 少数股东权益 | 3,015,277,801.6 | 3,014,521,277.94 | 3,115,727,470.37 | 3,114,250,123.34 |
| 股东权益合计 | 21,912,703,577.49 | 21,624,484,553.51 | 21,545,673,641.86 | 21,250,421,925.04 |
| 负债和股东权益合计 | 49,123,776,186.09 | 49,096,270,979.03 | 50,558,862,580.68 | 50,426,135,786.96 |
| 公告日期 | 2026-04-30 | 2026-04-02 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |